发明名称 System for targeted delivery of therapeutic agents
摘要 The present invention provides a drug delivery system for targeted delivery of therapeutic agent-containing particles to tissues, cells, and intracellular compartments. The invention provides targeted particles comprising a particle, one or more targeting moieties, and one or more therapeutic agents to be delivered and pharmaceutical compositions comprising inventive targeted particles. The present invention provides methods of designing, manufacturing, and using inventive targeted particles and pharmaceutical compositions thereof.
申请公布号 US8802153(B2) 申请公布日期 2014.08.12
申请号 US201313950804 申请日期 2013.07.25
申请人 Massachusetts Institute of Technology;The Brigham and Women's Hospital, Inc. 发明人 Cheng Jianjun;Farokhzad Omid C.;Langer Robert S.;Teply Benjamin A.;Zale Stephen E.
分类号 A61K9/14;A61K38/00;C12N15/11 主分类号 A61K9/14
代理机构 Pabst Patent Group LLP 代理人 Pabst Patent Group LLP
主权项 1. A targeted particle comprising a polymer conjugated to a surfactant, hydrophilic polymer or lipid, Wherein the particle is a nanoparticle having bound thereto a plurality of small molecule targeting moieties that specifically bind to the Zn2+ NAAG/PSMA binding pocket within prostate specific membrane antigen (PSMA) selected from the group consisting of 2-PMPA, GP15232, VA-033 2 MPPA, 2-MPPA, thiol and indole thiol based PSMA inhibitors, 3-(2-mercaptoethyl)-1H-indole-2-carboxylic acid derivative PSMA inhibitors, hydroxamate derivative PSMA inhibitors, PDBA-based PSMA inhibitors, and urea-based PSMA inhibitors, and having encapsulated or dispersed therein a taxane.
地址 Cambridge MA US